Gene · 100689229
H3P12: H3 histone pseudogene 12
12 sourcesgene-search-2026-11-11-0.2.0
Download JSON
Cite this record
ConductScience Library. H3P12: H3 histone pseudogene 12. Genes, record 100689229. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/100689229
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants878
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | H3P12 papers | Newest fiscal year |
|---|---|---|---|
| P01CA022443 | Molecular Biology and Genetics of Human Tumor Viruses | 8 | 2025 |
| P01HL136275 | Immune Cell Interactions in Atherosclerosis | 6 | 2025 |
| P30CA016672 | Cancer Center Support Grant | 5 | 2025 |
| P30AI027763 | UCSF-Bay Area Center for AIDS Research | 3 | 2025 |
| P30CA014520 | UW Comprehensive Cancer Center Support | 3 | 2025 |
| P30CA016058 | Cancer Center Support Grant | 3 | 2025 |
| R35HL145241 | Vascular macrophages and T cells in atherosclerosis | 3 | 2025 |
| ZIAAI000058 | Pathogenesis and Chemotherapy of Human Virus Infections | 3 | 2025 |
| K12CA133250 | OSU K12 Training Grant in Oncology | 2 | 2025 |
| P20GM130457 | COBRE in Digestive and Liver Disease | 2 | 2025 |
1 to 10 of 878Source NIH's project files
See all 878 nih grantsPapers1,298
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| ApoB-specific CD4+ T cells in atherosclerosis: MHC-II antigen presentation, T cell plasticity, and immune tolerance. | Front Immunol | 2026 | 42787603 | PubTator, text mining | PubMed |
| Dynamics of IgM and IgG responses in Lyme neuroborreliosis - a Norwegian longitudinal study. | Eur J Clin Microbiol Infect Dis | 2026 | 42618697 | PubTator, text mining | PubMed |
| Epstein-Barr virus-related antibody traits and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomization study. | Arch Med Sci | 2026 | 42540437 | PubTator, text mining | PubMed |
| A causal association between Epstein-Barr virus infection and lung cancer: A two-sample Mendelian Randomization study. | Cancer Biomark | 2026 | 42400365 | PubTator, text mining | PubMed |
| Inhibition of calpain-mediated BAX cleavage attenuates Japanese encephalitis virus-induced apoptosis in SH-SY5Y neuroblastoma cells. | Virol J | 2026 | 42393722 | PubTator, text mining | PubMed |
| Antibody-mediated immune responses and cardiovascular disease: a Mendelian randomization study. | Exp Biol Med (Maywood) | 2026 | 42206080 | PubTator, text mining | PubMed |
| Dissecting aphid transmission determinants in Citrus Tristeza Virus using chimeric viruses and gene substitutions. | Virology | 2026 | 42061270 | PubTator, text mining | PubMed |
| Causal effects of Epstein-Barr virus antibodies on autoimmune neuroinflammatory diseases: A generalised summary data-based Mendelian randomisation study. | Medicine (Baltimore) | 2026 | 41961712 | PubTator, text mining | PubMed |
| Endogenous and environmental factors that induce DNA replication defects and genomic instability in ER-negative heterozygous BRCA1 cells. | Sci Rep | 2026 | 41896346 | PubTator, text mining | PubMed |
| Unveiling the Molecular Blueprint of Spinach Induced Anti-proliferation and Pro-apoptosis in Cervical Cancer. | Anticancer Res | 2026 | 41895747 | PubTator, text mining | PubMed |
1 to 10 of 1,298
See all 1,298 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/100689229
GET https://conductscience.org/api/genes/v1/100689229/grants?page=2